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The science fiction film Fantastic Voyage was released in 
the United States in 1966. Its plotline, preceding nanotech-
nology by many years, begins with a scientist who needs 
emergency medical treatment for a stroke. However, this 
surgery can only be accomplished from inside his body. 
Intrepid medical personnel enter a submarine, which 
becomes miniaturized and is injected into a blood vessel. 
The submarine dodges red blood cells and macrophages 
as it sweeps through the heart, and the crew exits the 
submarine and is tossed about in the winds of the lungs. 
The special effects were among the most creative (and 
psychedelic) of the time, winning the film two Academy 
Awards. The voyage through the body took viewers into 
an intimate adventure where biologic reactions controlled 
all events. Though the science was sometimes flawed, the 
models of the interior of a blood vessel were stunning. One 
could hardly find a better documented microscopic view of 
the cardiovascular system.
But now, put away that microscope. Stand at the 
patient’s bedside and speak with his family. Step back 
and pause in the hospital emergency room; travel in the 
emergency response vehicle. Helicopter above the city and 
observe the worksites and schools. At higher elevations, 
look for the neighborhoods and the urban centers. Fly 
across the country and find the rural communities and the 
ethnic enclaves; circle the state and national legislative 
houses. In the United States in 2000 more than 711,000 
deaths from heart attack and 168,000 deaths associated 
with stroke occurred, representing 37% of all deaths in the 
country (1). If we are to protect people from heart attack 
and stroke, we must move beyond intravascular space 
to understand the cultures, behaviors, and systems that 
contribute to the risk factors that cause cardiovascular 
disease.
This issue of Preventing Chronic Disease explores how 
public health programs can be used in conjunction with 
the efforts of private and public groups to reduce the 
morbidity and mortality of cardiovascular disease. We 
thank Ms Mirium Patanian of the Cardiovascular Health 
Council, Washington State Department of Health, and 
Dr Nell Brownstein of the Division for Heart Disease and 
Stroke Prevention, National Center for Chronic Disease 
Prevention and Health Promotion, Centers for Disease 
Control and Prevention, for serving as guest editors for 
this issue. Ms Patanian and Dr Brownstein discuss the 
issue’s articles in depth (2,3), setting forth the challenges 
of addressing these complex diseases and reiterating our 
recognition that multiple contextual factors affect their 
prevalence.
We are on our own fantastic voyage. Since the mid–20th 
century we have learned methods — including decreas-
ing tobacco use, controlling high blood pressure, reducing 
dietary fat, and improving clinical care — for reducing the 
mortality and morbidity associated with cardiovascular 
disease. Between 1950 and 2004, cardiovascular disease 
death rates dropped from 587 to 217 per 100,000 age-
adjusted population (5), and stroke deaths dropped from 
181 to 50 (4).
We have projected a virtual tour of the country, because 
the next advances in heart attack and stroke reduction will 
depend not only on individual behaviors and medical care 
but also on population-based interventions (5). We must 
better understand the reasons for racial and ethnic dif-
ferences in disease and death rates, explore opportunities 
to reach underserved populations, and develop policy and 
environmental strategies for protecting people at risk. We 
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will continue to explore newly recognized factors that may 
affect disease prevalence, such as genetics and infectious 
agents. National surveillance of morbidity and mortality 
related to cardiovascular disease and community-level 
interventions are needed. We will design better secondary 
interventions to reduce disability and improve quality of 
life for people with existing cardiovascular conditions.
Fantastic Voyage ends as the crew of five, minus the evil 
scientist, saves one man’s life and escapes through a tear 
duct. For heart attack and stroke, the health of millions of 
people is at stake, and we do not have the luxury of five 
health professionals for each person at risk. No psychedelic 
adventures appear to be in store for us; it will require more 
than science fiction submarines and a handful of heroes 
to continue improving health. But based on our history in 
combating these events, the future looks promising.
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